National Donor Deferral Registry (NDDR) Helps Ensure That Deferred Donors Cannot Donate Their Plasma Again
The National Donor Deferral Registry (NDDR) is a database of permanently deferred plasma donors in North America. It is one of many voluntary, self-regulating initiatives taken by the source plasma collection industry and is an important component of the industry-driven safety measures taken to help ensure the safety of the final therapies.
All donors who test "reactive" for the viral agents for HIV, HBV and HCV are added to the NDDR and are permanently prohibited from donating source plasma at participating licensed and industry-certified centers in the U.S. and Canada.
The NDDR first was made available to all blood and source plasma facilities in December 1993. Haemonetics, a valued partner of PPTA, is responsible for the administration and customer support services of the NDDR.
All inquires should be directed to the NDDR Customer Support Desk at 1-877-534-3578.
International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases +
Annapolis, MD--The second annual International Plasma Awareness Week (IPAW) will be celebrated October 12-18. A joint initiative of the Plasma Protein Therapeutics Association (PPTA) and its member companies, IPAW is designed to:Read More
PPTA 2014 Business Forum +
Registration now open!
The 2014 PPTA Business Forum will be held October 26th in Philadelphia, Pennsylvania.
[This event is for PPTA Members Only]Read More
Initiation of the Five Week Enrollment Period for the Medicare IVIG Demonstration Project +
August 8, 2014—PPTA is pleased to announce the initiation of the five week enrollment period for the Medicare IVIG Demonstration Project beginning today.Read More
PPTA Standards Programs